Two U.S. companies teamed up to treat cancer patients using an unproven blood filter in Antigua, out of reach of American regulators.

© Javier Jaén

The company built a cheaper, competitive chatbot with fewer high-end computer chips than U.S. behemoths like Google and OpenAI, showing the limits of chip export control.